Category: News

RAMP named to the streaming media 100 for 2013

Boston, MA – Oct. 3, 2013 – RAMP, the industry’s leading provider of next generation video and search experiences for media and enterprises, today announced

Adamas Pharmaceuticals presents positive clinical data for ADS-5102

Results from the Phase 2/3 EASED Trial Demonstrate an Increase of Approximately Three Hours in ON Time Without Troublesome Dyskinesia for Patients Taking ADS-5102 Compared

PatientSafe Solutions Raises Strategic Investment from Singapore Fund EDBI to expand

September 24, 2013 – PatientSafe Solutions, a leader in point-of-care patient safety clinical workflow applications, today announced that it has closed a strategic investment from

Enlighted Inc. enters into partnership with Singapore strategic investment firm EDBI

SUNNYVALE, Calif. and SINGAPORE—September 9, 2013 – Enlighted Inc., a leader in solutions for improving the effectiveness and value of commercial buildings and real estate worldwide,

FDA grants qualified infectious disease product designation and fast track status for MerLion Pharma

Singapore, 22nd August 2013 – MerLion Pharmaceuticals (MerLion) announced today that the U.S. Food and Drug Administration (FDA) has designated finafloxacin for oral and intravenous (iv)

Ivantis raises additional $5M from Singapore-based global investor EDBI increasing Series B

Ivantis, developer of the novel Hydrus™ Microstent device designed to lower eye pressure for glaucoma patients, announced today that it secured an additional $5 MM in

Appcelerator raises $12.1M to drive mobile enterprise

MOUNTAIN VIEW, CA – July 16, 2013 – Appcelerator®, the leading mobile enterprise platform company, today announced it has raised $12.1 million in new capital to

Abbott to enter laser cataract surgery market through acquisition of OptiMedica

ABBOTT PARK, Ill., July 15, 2013 – Abbott today announced it has entered into an agreement to purchase OptiMedica Corporation, a privately held, Silicon Valley-based ophthalmic

Connecting Teams in the Cloud for Faster Clinical Study

Please describe the background to the establishment of goBalto

Forma Therapeutics & Cancer Research Technology to discover cancer drug targeting

Unique Business Model Implements Independent, Wholly Owned Asset Discovery and Development Company (ADDCo) Subsidiaries for Target Programs